NunaBio

News

19 July 2021

NunaBio Appoints Independent Board Chair

NunaBio Ltd are delighted to appoint Colin Mitchell as their new independent Board Chair.

Colin is a veterinary surgeon with 18 years’ experience as a business owner. He has also previously been appointed non-executive director and chair of financial committee for two other businesses. His qualifications and interests in finance, strategy and governance strongly support a Board-level position with NunaBio and it is with great pleasure that we welcome him to this.

CEO Joe Hedley says “Colin has a wealth of experience in roles across business, finance and strategy, which brings an understanding and perspective that will be essential for the role. It is a fantastic appointment which confirms our ambition to take NunaBio to the next level.”

Commenting on his appointment, Colin says “I am delighted and honoured to have been appointed as chair of NunaBio. As a business owner local to the North East I am very much looking forward to being involved in this company which has such an exciting future.”

Working with NunaBio


We work through detail design, integration and initial testing, repeating this process to optimise the design before verification testing.

Our work is fully documented and a package of data and specifications can be assembled to allow scale up manufacture to start smoothly.  

We have extensive experience in Process Validation, Project Management to Phase 2 Manufacturing Criteria, Change Management and Quality Assurance to Regulatory standards (MHRA; FDA). 

Our operations management is led by a Lead Auditor qualified in Quality Management (ISO9001), Medical Devices (ISO13485), Laboratory Testing (ISO17025), Information Security (ISO27001), and Environmental Management (ISO14001).  

Let's talk